Literature DB >> 21049561

Staging systems for predicting survival of patients with hepatocellular carcinoma after surgery.

Lei-Bo Xu1, Jie Wang, Chao Liu, Hao-Wei Pang, Ya-Jin Chen, Qing-Jia Ou, Ji-Sheng Chen.   

Abstract

AIM: To compare the staging systems for stratifying and predicting the prognosis of patients with hepatocellular carcinoma (HCC) after partial hepatectomy (PH).
METHODS: Clinical data about 438 HCC patients who underwent PH from January 1991 to December 2004 at our hospital were retrospectively analyzed. Tumor stage was evaluated following the Chinese tumor node metastasis (TNM) and barcelona clinic liver cancer (BCLC) staging systems, respectively. Survival curves for the HCC patients were plotted using the Kaplan-Meier method and differences were compared by the log-rank test. The accuracy of each system for predicting death of HCC patients was evaluated by calculating the area under the receiver operating characteristic curve.
RESULTS: The HCC patients were classified into stages I-III, stages I-IV and stages A-C, according to the 3 staging systems, respectively. Log-rank test showed that the cumulative survival rate was significantly different for the HCC patients at 3 Chinese system stages, TNM stages I and II, TNM stages III and IV, and 3 BCLC stages (P < 0.05). However, no significant difference was found in the HCC patients at TNM stages II and III. The accuracy of the Chinese and BCLC staging systems was higher than that of the TNM staging system for predicting the survival rate of HCC patients.
CONCLUSION: The Chinese and BCLC staging systems are better for stratifying and predicting the prognosis of HCC patients after PH than the TNM staging system.

Entities:  

Mesh:

Year:  2010        PMID: 21049561      PMCID: PMC2975098          DOI: 10.3748/wjg.v16.i41.5257

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  21 in total

1.  Prospective validation of the Cancer of the Liver Italian Program (CLIP) score: a new prognostic system for patients with cirrhosis and hepatocellular carcinoma.

Authors:  J M Llovet; J Bruix
Journal:  Hepatology       Date:  2000-09       Impact factor: 17.425

2.  Proposal of a new prognostic model for hepatocellular carcinoma: an analysis of 403 patients.

Authors:  R Tateishi; H Yoshida; S Shiina; H Imamura; K Hasegawa; T Teratani; S Obi; S Sato; Y Koike; T Fujishima; M Makuuchi; M Omata
Journal:  Gut       Date:  2005-03       Impact factor: 23.059

Review 3.  Hepatocellular carcinoma pathogenesis: from genes to environment.

Authors:  Paraskevi A Farazi; Ronald A DePinho
Journal:  Nat Rev Cancer       Date:  2006-09       Impact factor: 60.716

Review 4.  Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score).

Authors:  Masatoshi Kudo; Hobyung Chung; Yukio Osaki
Journal:  J Gastroenterol       Date:  2003       Impact factor: 7.527

5.  Global cancer statistics, 2002.

Authors:  D Max Parkin; Freddie Bray; J Ferlay; Paola Pisani
Journal:  CA Cancer J Clin       Date:  2005 Mar-Apr       Impact factor: 508.702

Review 6.  Prognostic factors of hepatic resection for hepatocellular carcinoma with cirrhosis: univariate and multivariate analysis.

Authors:  Chun-Nan Yeh; Miin-Fu Chen; Wei-Chen Lee; Long-Bin Jeng
Journal:  J Surg Oncol       Date:  2002-12       Impact factor: 3.454

7.  Comparison of clinical staging systems in predicting survival of hepatocellular carcinoma patients receiving major or minor hepatectomy.

Authors:  T W Chen; C M Chu; J C Yu; C J Chen; D C Chan; Y C Liu; C B Hsieh
Journal:  Eur J Surg Oncol       Date:  2006-11-28       Impact factor: 4.424

8.  Prognosis of hepatocellular carcinoma: the BCLC staging classification.

Authors:  J M Llovet; C Brú; J Bruix
Journal:  Semin Liver Dis       Date:  1999       Impact factor: 6.115

9.  Review of current staging systems for hepatocellular carcinoma.

Authors:  Hobyung Chung; Masatoshi Kudo; Shunsuke Takahashi; Satoru Hagiwara; Yasuhiro Sakaguchi; Tatsuo Inoue; Yasunori Minami; Kazuomi Ueshima; Toyokazu Fukunaga
Journal:  Hepatol Res       Date:  2007-09       Impact factor: 4.288

10.  Cancer statistics, 2009.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Yongping Hao; Jiaquan Xu; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2009-05-27       Impact factor: 508.702

View more
  7 in total

1.  OATP 1B1/1B3 expression in hepatocellular carcinomas treated with orthotopic liver transplantation.

Authors:  Francesco Vasuri; Rita Golfieri; Michelangelo Fiorentino; Elisa Capizzi; Matteo Renzulli; Antonio D Pinna; Walter F Grigioni; Antonia D'Errico-Grigioni
Journal:  Virchows Arch       Date:  2011-06-21       Impact factor: 4.064

2.  Post-hepatectomy survival in advanced hepatocellular carcinoma with portal vein tumor thrombosis.

Authors:  Yusuke Yamamoto; Hisashi Ikoma; Ryo Morimura; Katsutoshi Shoda; Hirotaka Konishi; Yasutoshi Murayama; Shuhei Komatsu; Atsushi Shiozaki; Yoshiaki Kuriu; Takeshi Kubota; Masayoshi Nakanishi; Daisuke Ichikawa; Hitoshi Fujiwara; Kazuma Okamoto; Chouhei Sakakura; Toshiya Ochiai; Eigo Otsuji
Journal:  World J Gastroenterol       Date:  2015-01-07       Impact factor: 5.742

Review 3.  Situs Inversus Totalis (SIT) with Hepatocellular Carcinoma (HCC): A Rare Case Report and Review of 12 Other Cases.

Authors:  Rajan B Patel; Natvar R Gupta; Nitin C Vasava; Janak R Khambholja; Sanjay Chauhan; Amit Desai
Journal:  Indian J Surg       Date:  2012-10-10       Impact factor: 0.656

4.  Validation of the 7th edition TNM staging system for hepatocellular carcinoma: an analysis of 8,828 patients in a single medical center.

Authors:  Kwong-Ming Kee; Jing-Houng Wang; Chih-Yun Lin; Chih-Chi Wang; Yu-Fan Cheng; Sheng-Nan Lu
Journal:  Dig Dis Sci       Date:  2013-05-24       Impact factor: 3.199

5.  Evaluation of the new AJCC staging system for resectable hepatocellular carcinoma.

Authors:  Chih H Cheng; Chen F Lee; Tsung H Wu; Kun M Chan; Hong S Chou; Ting J Wu; Ming C Yu; Tse C Chen; Wei C Lee; Miin F Chen
Journal:  World J Surg Oncol       Date:  2011-09-30       Impact factor: 2.754

6.  Effects and Relative Factors of Adjunctive Chinese Medicine Therapy on Survival of Hepatocellular Carcinoma Patients: A Retrospective Cohort Study in Taiwan.

Authors:  Yu-Pei Liao; Pei-Tseng Kung; Yueh-Hsin Wang; Yeong-Ruey Chu; Shung-Te Kao; Wen-Chen Tsai
Journal:  Integr Cancer Ther       Date:  2020 Jan-Dec       Impact factor: 3.279

7.  Systematic review of the outcomes of surgical resection for intermediate and advanced Barcelona Clinic Liver Cancer stage hepatocellular carcinoma: A critical appraisal of the evidence.

Authors:  Ye Xin Koh; Hwee Leong Tan; Weng Kit Lye; Juinn Huar Kam; Adrian Kah Heng Chiow; Siong San Tan; Su Pin Choo; Alexander Yaw Fui Chung; Brian Kim Poh Goh
Journal:  World J Hepatol       Date:  2018-06-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.